Press Releases
-
Oncology news: Capnopharm announces asset purchase of Capnomed as PIPAC™ shows superiority over IV Chemotherapy in first randomised data presented at ASCO 2022
Capnopharm GmbH today announced it has entered into an asset purchase agreement to acquire all operating assets from Capnomed GmbH.
Jul 6, 2022
-
Vaccizone selects Exothera for process development and GMP manufacturing of its SARS‑CoV‑2 vaccine based on proprietary ASC technology
Vaccizone has selected Exothera S.A. to fast-track process development of its SARS‑CoV‑2 vaccine for European clinical trials.
Jul 5, 2022
-
DFE Pharma expands its inhalation portfolio with the launch of Lactohale® 400
DFE Pharma expands its inhalation portfolio with the launch of Lactohale® 400 Being a leader in Dry Powder Inhalation, DFE Pharma further expands its broad excipient portfolio of inhalation grade lactose
Jul 4, 2022
-
CD Formulation Enlarges Particulate Matter Testing Capability
-
A Comprehensive Portfolio of Hydrophobic Polymers Makes Breakthroughs Closer
-
BOC Sciences New Promotes: Comprehensive Oligo Synthesis Service Package
-
BOC Sciences Fermentation CDMO Services Prompt a New Era for Pharmaceutical Compound Production
-
BOC Sciences Contributes to a Large Portion of PseudoUridine Production for mRNA Vaccine R&D
-
BOC Sciences Commitment at BIO 2022: From Concept to GMP Production
-
IgGenix Demonstrates Potential for Single-Cell RNA-Sequencing in Tree Nut Allergies
-
CD ComputaBio Boosts Your Disease Research with Computational Proteomics Service
-
Clinical Data Management: What Are The Key Challenges And How To Navigate Them?
In this post, learn about key challenges of clinical data management face and see what the future holds for CDMS System
Jun 30, 2022
-
Innovative Impurity Isolation and Identification Techniques at BOC Sciences to Address Pharmaceutical Impurity Issues
BOC Sciences announced impurity isolation and identification services using traditional and innovative impurity techniques.
Jun 29, 2022
-
Introducing Inizio: Ashfield and Huntsworth unite expertise to form powerful strategic partner for health and life sciences companies
-
Aspergillus Species Fermentation Platforms: Suit The Needs in Scale-up and cGMP Fermentation
-
Creative Biogene Provides Support for The Entire Adenovirus Construction and Virus Packaging
-
Y2H cDNA Library Screening Service: Supporting Gene Functional Analysis and Potential Drug Target Discovery
-
Creative Bioarray Develops Customized Approaches of Immunohistochemistry Services to Accelerate Biological Projects
-
Creative Bioarray Develops Viable Medthods to Support Stem Cell Generation
-
Creative Bioarray Provides Comprehensive iPSC Characterization Service to Support Stem Cell Research